251. Effects of all- trans-retinoic on human gastric cancer cells BGC-823.
- Author
-
Jin Ping ZHANG, Xiang Yu CHEN, and Jian Sheng LI
- Subjects
TRETINOIN ,GASTRIC diseases ,CANCER cells ,CELL growth ,VASCULAR endothelial growth factors ,CELL cycle ,MESSENGER RNA - Abstract
OBJECTIVE: To determine the inhibitory effects of all- trans-retinoic acid (ATRA) on cell growth, cell cycle and vascular endothelial growth factor (VEGF) expression in the human gastric cancer cell line BGC-823 in vitro. METHODS: Human gastric cancer BGC-823 cells were treated with various concentrations of ATRA and the cell growth was then determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide viability assay. The cell cycle distribution was analyzed using a flow cytometer. The VEGF mRNA and protein expression were analyzed by semi-quantitative RT-PCR and Western blotting, respectively. RESULTS: ATRA at concentrations of 0.1–10 µmol/L inhibited the growth of BGC-823 cells grown in culture; a time- and dose-dependent inhibitory influence was found. ATRA arrested BGC-823 cells at the G
0 /G1 phase in a dose-dependent way. Both VEGF mRNA and protein were decreased by ATRA in a dose-dependent way. CONCLUSION: The anti-tumor effects of ATRA on human gastric cancer cells are associated with G0 /G1 phase arrest and decreased VEGF expression. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF